Trade

with

Baxter International Inc
(NYSE: BAX)
AdChoices
67.94
+0.70
+1.04%
After Hours :
67.94
0.00
0.00%

Open

67.28

Previous Close

67.24

Volume (Avg)

3.20M (2.36M)

Day's Range

66.81-67.95

52Wk Range

64.78-77.31

Market Cap.

36.80B

Dividend Rate (Yield )

- (2.97%)

Beta

0.72

Shares Outstanding

541.67M

P/E Ratio (EPS)

19.12 (3.55)

AdChoices
Financials
  • Income Statement
  • Balance Sheet
  • Cash Flow
Operating Income
2.67B
Operating Margin
17.48
Total Equity
-
Retained Earnings
-
Free Cashflow
-
Price/Cashflow
-
Company Profile

Sector

Healthcare

Industry

Medical Instruments & Supplies

Type

Classic Growth

Style

Large Core

Baxter International Inc is a Delaware corporation incorporated in 1931. The Company is a healthcare company engaged in the development, manufacture and sale of products that save and sustain the lives of people with hemophilia, immu...morene disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The Company applies a combination of medical devices, pharmaceuticals and biotechnology to create products that advance patient care. These products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, clinical and medical research laboratories, and by patients at home under physician supervision. The Company operates in two segments namely BioScience and Medical Products. The BioScience business processes recombin...moreant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as bio surgery products; and vaccines. The Medical Products business manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics, as well as products and services related to pharmacy compounding, drug formulation and packaging technologies. The business manufactures solutions and other products for peritoneal dialysis, a home-based therapy, and also distributes products for hemodialysis, which is generally conducted in a hospital or clinic. The Company has its own direct sales force and also makes sales to and through independent distributors, drug wholesalers acting as sales agents and specialty pharmacy or other alternate site providers. The Company faces substantial competition in each of its segments from international and domestic healthcare and pharmaceutical companies of all sizes. The BioScience segment faces competitors from pharmaceutical, biotechnology and other companies. The Medical Products segment faces competition from medical device manufacturers and pharmaceutical companies. The Company’s operations and many of the products manufactured or sold by the Company are subject to extensive regulation by numerous government agencies, both within and outside the United States.lessless

Key People

Robert L. Parkinson,Jr

CEO/Chairman of the Board/Director

Mr. Robert J. Hombach

CFO/Vice President

Jean-Luc Butel

President, Divisional/Vice President

Jeanne K. Mason

Vice President, Divisional

Mr. David P. Scharf

General Counsel/Vice President/Secretary

Incorporated

1931

Employees

-